A histopathological study on breast carcinoma with special reference to cyclin-D1 and estrogen receptor

Abstract

Introduction:  Breast cancer is the most frequent cause of cancer-related death in women in developing nations. Breast cancer diagnoses have increased as a result of rising awareness among women. The expression of Estrogen receptors (ER) plays a crucial role in determining the responsiveness to specific treatments. Cyclin D1 being a marker for cell proliferation was used in this study. The primary objectives of the current investigation were to investigate the expression of Cyclin-D1 and Estrogen receptor (ER) in breast carcinoma and to establish a relationship between the expression patterns of Cyclin-D1 and ER with the histopathological features of the tumor in breast carcinoma.  

Materials and methods: The study was conducted in the Department of Pathology, Silchar Medical College and Hospital, Silchar, India, from June 2021 to May 2022. A total of 59 cases of primary breast carcinoma MRM(Modified radical mastectomy)  specimens were included in the study.

Results: The mean age of the patients was 52.12 ± 12.47 years, and the majority of the patients were in the post-menopausal phase. Lymph node metastasis was observed in 47.5% of the cases, and the majority of the cases were in grade II. The study demonstrated a trend towards increased Cyclin-D1 and ER-positive with aging. Cyclin-D1 positivity decreases and Cyclin-D1 negativity increases as the tumor growth increases. The study showed a statistically significant association (P=0.001) between ER and Cyclin-D1. The majority of post-menopausal patients had ER-positive.

Conclusion: The present study provides the incidence of different parameters associated with breast carcinoma and their statistical correlation with CyclinD1 and ER that will provide improved and crucial treatment guidance.